Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Bauman MD"'
Autor:
Andrew J. Arifin, MD, Sympascho Young, MD, Glenn S. Bauman, MD, Hatim Fakir, PhD, Belal Ahmad, MD, Joanna M. Laba, MD, George B. Rodrigues, MD, PhD, Eric K. Nguyen, MD, Arjun Sahgal, MD, Timothy K. Nguyen, MD, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101220- (2023)
Purpose: The goal of this study was to assess the potential real-world effect of the recently reported SC.24 trial on spine stereotactic body radiation therapy (SBRT) utilization. We estimated the proportion of patients treated with conventional radi
Externí odkaz:
https://doaj.org/article/20a6e337d7c143a7b5fc88c830acec0f
Autor:
Sympascho Young, MD, Kiran Phaterpekar, BSc, Derek S. Tsang, MD, Gabriel Boldt, MLIS, Glenn S. Bauman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101189- (2023)
Purpose: The aim of this study was to comprehensively review all studies examining clinical outcomes of craniospinal irradiation with proton radiotherapy for medulloblastoma (MB) to determine whether theoretical dosimetric advantages have translated
Externí odkaz:
https://doaj.org/article/072c6f3406694b5987a9596bf082cf05
Autor:
Mark T. Corkum, MD, MSc, Lucas C. Mendez, MD, MSc, Joseph Chin, MD, David D’Souza, MD, R. Gabriel Boldt, MLIS, Glenn S. Bauman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 965-977 (2020)
Purpose: Reirradiation (re-RT) using external beam radiation therapy (EBRT) is a novel salvage strategy for local failure in prostate cancer. We performed a systematic review describing oncologic and toxicity outcomes for salvage EBRT/stereotactic ra
Externí odkaz:
https://doaj.org/article/5d95777cc8c041ca95f5b9e9ecf7fb3f
Autor:
Christopher D. Goodman, MD, Hatim Fakir, PhD, Stephen Pautler, MD, Joseph Chin, MD, Glenn S. Bauman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 2, Pp 212-220 (2020)
Purpose: Prostate cancer is multifocal. However, there often exists a single dominant focus in the gland responsible for driving the biology of the disease. Dose escalation to the dominant lesion is a proposed strategy to increase tumor control. We a
Externí odkaz:
https://doaj.org/article/df615000d3204a639df62f0e3db7f4df
Autor:
Laura Callan, MD, MASc, Glenn Bauman, MD, Jeff Chen, PhD, Michael Lock, MD, Tracy Sexton, MD, PhD, David D'Souza, MD, George Rodrigues, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 668-673 (2019)
Purpose: FASTR was designed to provide a compact treatment course for high-risk prostate cancer patients but was discontinued because of excess toxicity. We present the results of FASTR-2, which used a lower dose to the prostate (35 Gy vs 40 Gy), sma
Externí odkaz:
https://doaj.org/article/a93c4350a6474d16b6f71d7b6bc816f1
Autor:
Mark T. Corkum, MD, MSc, Hatim Fakir, PhD, David A. Palma, MD, PhD, Timothy Nguyen, MD, Glenn S. Bauman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100734- (2021)
Purpose: Phase 2 randomized trials suggest that stereotactic ablative radiation therapy improves progression-free and overall survival in patients with oligometastatic cancer, with phase 3 trials currently testing stereotactic ablative radiation ther
Externí odkaz:
https://doaj.org/article/420c1eb76dd940148940cafc7f47da15
Publikováno v:
International Journal of Women's Dermatology, Vol 6, Iss 2, Pp 99-101 (2020)
Background: The risk of squamous cell carcinoma (SCC) is increased in solid organ transplant recipients (OTRs), and preferential treatment modalities vary among clinicians. Objectives: The purpose of this study was to survey dermatologists regarding
Externí odkaz:
https://doaj.org/article/dd79b8ffe5534f67af3d735b2a93d523
Autor:
Wei Liu, MD, Katherine Zukotynski, MD, PhD, FRCPC, Louise Emmett, MD, FRACP, Hans T. Chung, MD, FRCPC, Peter Chung, MD, FRCPC, Robert Wolfson, MD, FRCPC, Irina Rachinsky, MD, MSc, FRCPC, Anil Kapoor, MD, FRCSC, Ur Metser, MD, FRCPC, Andrew Loblaw, MD, MSc, FRCPC, Gerard Morton, MB, FRCPC, Tracy Sexton, MD, PhD, FRCPC, Michael Lock, MD, FRCPC, Joelle Helou, MD, MSc, Alejandro Berlin, MD, MSc, Colm Boylan, MB, FRCPC, Susan Archer, BSc, Gregory R. Pond, PhD, PStat, Glenn Bauman, MD, FRCPC
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100553- (2021)
Purpose: Our purpose was to investigate the effect of the addition of prostate-specific membrane antigen (PSMA)-targeted positron emission tomography/computed tomography (PET/CT) in patients with recurrent prostate cancer post-primary radiation thera
Externí odkaz:
https://doaj.org/article/25489d44ab854ea895ee08cf664a57f7
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 1, Pp 1-5 (2017)
Externí odkaz:
https://doaj.org/article/4c26979c62444513a6b92ad6a1803748
Publikováno v:
Expert Review of Anticancer Therapy; Oct2022, Vol. 22 Issue 10, p1029-1038, 10p